SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Chu L, Robinson DK. Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol. 2001;12:180187.
  • 2
    Ryll T, Dutina G, Reyes A, Gunson J, Krummen L, Etcheverry T. Performance of small-scale CHO perfusion cultures using an acoustic cell filtration device for cell retention: characterization of separation efficiency and impact of perfusion on product quality. Biotechnol Bioeng. 2000;69:440449.
  • 3
    Mercille S, Johnson M, Lanthier S, Kamen AA, Massie B. Understanding factors that limit the productivity of suspension-based perfusion cultures operated at high medium renewal rates. Biotechnol Bioeng. 2000;67:435450.
  • 4
    Tang YJ, Ohashi R, Hamel J-F. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system. Biotechnol Prog. 2007;23:255264.
  • 5
    Voisard D, Meuwly F, Ruffieux PA, Baer G, Kadouri A. Potential of cell retention techniques for large-scale high-density perfusion culture of suspended mammalian cells. Biotechnol Bioeng. 2003;82:751765.
  • 6
    Chotteau V, Björling T, Boork S, Brink-Nilsson H, Chatzissavidou N, Fenge C, Lindner-Olsson E, Olofsson M, Rosenquist J, Sandberg H, Smeds A-L, Drapeau D. Development of a large scale process for the production of recombinant truncated factor VIII in CHO cells under cell growth arrest conditions. In: Lindner-Olsson E, Chatzissavidou N, Lüllau E, editors. Animal Cell Technology: From Target to Market. Proceedings of the 17th ESACT Meeting, Tylösand, Sweden, June 10–14, 2001. Dordrecht: Kluver Academic Publisher; 2001:287292.
  • 7
    Johnson M, Lanthier S, Massie B, Lefebvre G, Kamen AA. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium. Biotechnol Prog. 1996;12:855864.
  • 8
    Kompala DS, Ozturk SS. Optimization of high cell density perfusion bioreactors. In: Ozturk SS, Hu W-S, editors. Cell Culture Technology for Pharmaceutical and Cell-Based Therapies. New York: Taylor & Francis; 2005:387416.
  • 9
    Pinto RC, Medronho RA, Castilho LR. Separation of CHO cells using hydrocyclones. Cytotechnology. 2008;56:5767.
  • 10
    Woodside SM, Bowen BD, Piret JM. Mammalian cell retention devices for stirred perfusion bioreactors. Cytotechnology. 1998;28:163175.
  • 11
    de la Broise D, Noiseux M, Lemieux R, Massie B. Long-term perfusion culture of hybridoma: a "grow or die" cell cycle system. Biotechnol Bioeng. 1991;38:781787.
  • 12
    Zhang Y, Stobbe P, Orrego CS, Chotteau V. Study of perfusion process of CHO cells with CellTank 2202 prototype, bench-top Single-Use-Bioreactors (SUB) with 150 cm3 CellCore matrix. In: 22nd ESACT-UK Meeting, Loughborough, UK, January 11–12, 2012.
  • 13
    Caron A, Tom R, Kamen A, Massie B. Baculovirus expression system scaleup by perfusion of high-density Sf-9 cell cultures. Biotechnol Bioeng. 1994;43:881891.
  • 14
    Cortin V, Thibault J, Jacob D, Garnier A. High-titer adenovirus vector production in 293S cell perfusion culture. Biotechnol Prog. 2004;20:858863.
  • 15
    Velez D, Miller L, Macmillan JD. Use of tangential flow filtration in perfusion propagation of hybridoma cells for production of monoclonal-antibodies. Biotechnol Bioeng. 1989;33:938940.
  • 16
    Yuk IH, Olsen MM, Geyer S, Forestell SP. Perfusion cultures of human tumor cells: a scalable production platform for oncolytic adenoviral vectors. Biotechnol Bioeng. 2004;86:637642.
  • 17
    Bleckwenn NA, Golding H, Bentley WE, Shiloach J. Production of recombinant proteins by vaccinia virus in a microcarrier based mammalian cell perfusion bioreactor. Biotechnol. Bioeng. 2005;90:663674.
  • 18
    Clincke MF, Molleryd C, Zhang Y, Lindskog E, Walsh K, Chotteau V. Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE Bioreactor. BMC Proc. 2011;5 (Suppl. 8):P105.
  • 19
    Furey J. Scale-up of a cell culture perfusion process—a low-shear filtration system that inhibits filter-membrane fouling. Genet Eng News. 2002;22:6262.
  • 20
    Singh V. Disposable bioreactor for cell culture using wave-induced agitation. Cytotechnology. 1999;30:149158.
  • 21
    Eibl R, Eibl D. Application of disposable bag bioreactors in tissue engineering and for the production of therapeutic agents. Adv Biochem Eng/Biotechnol. 2009;112:183207.
  • 22
    Lim J, Sinclair A. Process economy of disposable manufacturing: process models to minimize upfront investment. Am Pharm Rev. 2007;10:114121.
  • 23
    Kuczewski M, Schirmer E, Lain B, Zarbis-Papastoitsis G. A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line. Biotechnol J. 2011;6:5665.
  • 24
    Clincke MF, Molleryd C, Samani PK, Lindskog E, Fäldt E, Walsh K, Chotteau V. Very high density of CHO cells in perfusion by ATF or TFF in WAVE Bioreactor™—Part II. Applications for Antibody Production and Cryopreservation. Biotechnol Prog., in press.
  • 25
    Ozturk SS. Engineering challenges in high density cell culture systems. Cytotechnology. 1996;22:316.
  • 26
    Chotteau V, Tördal K, Perroud P. Study of a perfusion process of Chinese Hamster Ovary cells by ATF filtration in bioreactor. In: 21st ESACT Meeting, Dublin, Ireland, June 7–10, 2009.
  • 27
    Konstantinov K, Goudar C, Ng M, Meneses R, Thrift J, Chuppa S, Matanguihan C, Michaels J, Naveh D. The "push-to-low" approach for optimization of high-density perfusion cultures of animal cells. Adv Biochem Eng/Biotechnol. 2006;101:7598.
  • 28
    deZengotita V, Schmelzer A, Miller W. Characterization of hybridoma cell responses to elevated pCO(2) and osmolality: intracellular pH, cell size, apoptosis, and metabolism. Biotechnol Bioeng. 2002;77:369380.
  • 29
    Kimura R, Miller W. Effects of elevated pCO(2) and/or osmolality on the growth and recombinant tPA production of CHO cells. Biotechnol Bioeng. 1996;52:152160.
  • 30
    Takuma S, Hirashima C, Piret JM. Dependence on glucose limitation of the pCO2 influences on CHO cell growth, metabolism and IgG production. Biotechnol Bioeng. 2007;97:14791488.
  • 31
    Kyung YS, Peshwa MV, Gryte DM, Hu WS. High density culture of mammalian cells with dynamic perfusion based on on-line oxygen uptake rate measurements. Cytotechnology. 1994;14:183190.
  • 32
    Adams T, Noack U, Frick T, Greller G, Fenge C. Increasing efficiency in protein and cell production by combining single-use bioreactor technology and perfusion. BioPharm Int Suppl. 2011;24:411.
  • 33
    Wang L, Hu H, Yang J, Wang F, Kaisermayer C, Zhou P. High yield of human monoclonal antibody produced by stably transfected Drosophila schneider 2 cells in perfusion culture using wave bioreactor. Mol Biotechnol. 2012;52:170179.
  • 34
    Zoro BJ, Owen S, Drake RA, Mason C, Hoare M. Regenerative medicine bioprocessing: concentration and behavior of adherent cell suspensions and pastes. Biotechnol Bioeng. 2009;103:123647.
  • 35
    Malinowski JJ, Lafforgue C, Goma G. Rheological behavior of high-density continuous cultures of Saccharomyces cerevisiae. J Ferment Technol. 1987;65:319323.
  • 36
    Reuss M, Josic D, Popovic M, Bronn WK. Viscosity of yeast suspensions. Eur J Appl Microbiol. 1979;8:167175.
  • 37
    Curtis WR, Emery AH. Plant cell suspension culture rheology. Biotechnol Bioeng. 1993;42:520526.
  • 38
    Wu L, Ek M, Song M, Sichen D. The effect of solid particles on liquid viscosity. Steel Res Int. 2011;82:388397.
  • 39
    Russotti G, Osawa AE, Sitrin RD, Buckland BC, Adams WR, Lee SS. Pilot-scale harvest of recombinant yeast employing microfiltration: a case study. J Biotechnol. 1995;42:235246.
  • 40
    Castilho LR, Medronho RA. Cell retention devices for suspended-cell perfusion cultures. Adv Biochem Eng/Biotechnol. 2002;74:129169.
  • 41
    Zhang S, Handa-Corrigan A, Spier R. A comparison of oxygenation methods for high-density perfusion cultures of animal cells. Biotechnol Bioeng. 1993;41:685692.
  • 42
    Kawahara H, Mitsuda S, Kumazawa E, Takeshita Y. High-density culture of FM-3A cells using a bioreactor with an external tangential-flow filtration device. Cytotechnology. 1994;14:6166.
  • 43
    Thomas DG. Transient Characteristics of Suspensions: Part VIII. A Note on the Viscosity of Newtonian Suspensions of Uniform Spherical Particles. Journal Colloid Science. 1965;20:267.